5. Neoplasia V- Molecular Diagnostics Flashcards

1
Q

Define the function of tumor suppressor genes and oncogenes and how mutations in each lead to the development of malignancy (objective)

A

Answer later

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Name the basic steps of the polymerase chain reaction (PCR) and understand its role in current molecular diagnostics methodologies (objective)

A

Answer later

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Recognize the principles of some of the common basic molecular diagnostic techniques, including next generation sequencing, RT-PCR, Sanger sequencing, capillary electrophoresis, and pyrosequencing (objective)

A

Answer later

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the role of molecular diagnostics in diagnosis, prognosis, treatment modality, and clinical trials eligibility in patients with solid and hematopoietic tumors (objective)

A

Answer later

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the regulation of molecular diagnostic testing, including the difference between FDA-approved and laboratory developed tests (objective)

A

Answer later

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Need to know for summative

A

Oncogenes, tumor suppressor genes, Lynch syndrome, EGFR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Tumor Suppressor Genes

A
  1. Inhibit cell proliferation (Rb, TP53, P16)
  2. Loss of 2 alleles
  3. Accounts for many familial cancer syndromes (Lynch, BRA1/2)
  4. Large variety of mutation types seen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Tumor Suppressor HPV Induced Carcinogenesis

A

HPV leads to E6 and E7.

E6 shuts off P53/Bak, turns on telomerase and kinases leadings to cell immortalization

E7 does similar cell immortalization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Oncogenes

A
  1. Activation of cell cycle/cell proliferation (EGFR, growth and transcription factors)
  2. Usually specific activating point mutations, gene amplification and chromosome translocation/rearrangement)-gain of function
  3. Often therapeutic targets
  4. Familial syndromes are rare
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

2 Types of Tests in Molecular Lab

A
  1. Laboratory developed tests

2. FDA approved tests

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Polymerase chain reaction- PCR

A
  1. Denaturation (at 94-96 degrees C)
  2. Annealing (at 68 degrees C)
  3. Elongation (at 72 degrees C)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Sanger Sequencing

A
  1. Use of dye-labeled ddNTPs in elongation phase
  2. Run through capillary electrophoresis
  3. Can detect base pair substitutions and insertions/deletions
  4. Sensitivity of 10-20%
  5. Will NOT detect large rearrangements
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pyrosequencing

A
  1. Sequencing by synthesis (nucleotides added one at a time)
  2. Use of Luciferase, which interacts with ATP released when dNTP is added to elongating chain
  3. Sensitivity of 5%
  4. Detect base pair substitutions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Reverse Transcription PCR (RT-PCR)

A
  1. RNA translated into cDNA, then DNA amplified by PCR
    (fusion transcripts/translocations, gene expression)
  2. Don’t confuse with Real Time PCR (qPCR)
    - quantifies amount of DNA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Size discrimination by capillary electrophoresis

A
  • Amplification of Target Region of DNA

- Run through gel with control fragments of known size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Next Generation Sequencing (Massively Parallel Sequencing)

A
  1. DNA fragmented
  2. DNA ligated to uniquely coded sequences (primer site, hybridization site)
  3. DNA hybridized to substate (flow cell, bead)
  4. Sequencing
  5. Bioinformatics
17
Q

Lynch Syndrome

A

Hereditary cancer syndromes caused by mutation in 1 of 4 DNA mismatch repair proteins (form of tumor suppressor gene), MLH1, MSH2, MSH6, PMS2
-Deletion of 3’ exons of EPCAM gene, causing inactivation of MSH2
1. Hereditary non-polyposis colorectal cancer
2. Endometrial cancers
+ micro-satellite unstable (caused by hypermethylation of MLH1)

18
Q

Tests for Lynch Syndrome

A
  • micro-satellite instability: reflex MLH1 hypermethylation, reflex BRAF mutation testing
  • MMR protein expression by IHC: MLH1 hypermethylation
  • Gene sequencing
19
Q

EGFR Mutations in Non-Small Cell Lung Cancer

A

EGFR mutations in Exons 18/19/20/21

Primarily in adenocarcinoma histology, never smokers, females and Asians